Adventitial Nab-Rapamycin Injection Reduces Porcine Femoral Artery Luminal Stenosis Induced by Balloon Angioplasty via Inhibition of Medial Proliferation and Adventitial Inflammation-Reference-Cited by-同舟云学术

Adventitial Nab-Rapamycin Injection Reduces Porcine Femoral Artery Luminal Stenosis Induced by Balloon Angioplasty via Inhibition of Medial Proliferation and Adventitial Inflammation

Published:2013-12 Issue:6 Volume:6 Page:701-709
ISSN:1941-7640
Container-title:Circulation: Cardiovascular Interventions
language:en
Short-container-title:Circ Cardiovasc Interv

Author:

Gasper Warren J.¹,Jimenez Cynthia A.¹,Walker Joy¹,Conte Michael S.¹,Seward Kirk¹,Owens Christopher D.¹

Affiliation:

1. From the Departments of Vascular Surgery (W.J.G., J.W., M.S.C., C.D.O.) and Pathology (C.A.J.), University of California, San Francisco; and Mercator MedSystems, Inc, San Leandro, California (K.S.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Cost per day of patency: Understanding the impact of patency and reintervention in a sustainable model of healthcare

2. Quality of Life after Balloon Angioplasty versus Stent Implantation in the Superficial Femoral Artery: Findings from a Randomized Controlled Trial

3. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease

4. Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional Stenting

5. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticles as a Novel Platform for Cardiovascular Disease Diagnosis and Therapy;International Journal of Nanomedicine;2024-08

2. Recent advancements in nanotechnology based drug delivery for the management of cardiovascular disease;Current Problems in Cardiology;2024-04

3. Drug repurposing: A multi targetted approach to treat cardiac disease from existing classical drugs to modern drug discovery;Progress in Molecular Biology and Translational Science;2024

4. Microneedle biomedical devices;Nature Reviews Bioengineering;2023-12-21

5. Nanomedicines for cardiovascular disease;Nature Cardiovascular Research;2023-04-03